
Adicet Bio

Dr. Aya Jakobovits Ph.D. (Founder & Independent Director)
Mr. Brian Nicholas Harvey (Chief Financial Officer)
Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA (CEO, Pres & Director)
Summary
History
Adicet Bio was founded in 2016 with the aim of using monoclonal gamma delta T cells to treat cancer. In just a few years, with the help of our investors, Adicet has been able to develop groundbreaking technologies, secure breakthrough funding and secure strategic partnerships.
Mission
Vision
Key Team
Ms. Amy Locke (Head of HR)
Dr. Nancy L. Boman M.D., Ph.D. (Sr. VP & Chief Regulatory Officer)
Dr. Donald Healey (Chief Technology Officer)
Dr. Blake Aftab Ph.D. (Sr. VP & Chief Scientific Officer)
Dr. Francesco Galimi M.D., Ph.D. (Chief Medical Officer & Sr. VP)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dr. Aya Jakobovits Ph.D. (Founder & Independent Director)
Mr. Brian Nicholas Harvey (Chief Financial Officer)
Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA (CEO, Pres & Director)
